ArticleCureus2026

Tocilizumab as a Potential Alternative Therapy for Acute Exacerbation of Systemic Sclerosis-Associated Interstitial Lung Disease in a Dialysis Patient Following Immunodeficiency-Associated Lymphoproliferative Disorders.

Taiga Kuga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.